Personalised Electronic Record Supported Optimisation When Alone for Patients With Hypertension

A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 343 participants.

Also called NCT04559074

  • Study
  • In this atlas

Overview

Design
Interventional study; non-randomized; no masking; primary purpose treatment
Phase
Phase 4
Enrolled
  • 343 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT04559074
  • EudraCT 2020-002494-10
Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
United Kingdom (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT04559074. Non-randomized; no masking; primary purpose treatment. Start 2020-10-23 (actual); primary completion 2021-11-10 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Personalised Electronic Record Supported Optimisation When Alone for Patients With Hypertension
Acronym
PERSONALCovdBP
Condition
Hypertension
Intervention (Drug)
Amlodipine
Lead sponsor
Queen Mary University of London (class: other)
Collaborator
Closed Loop Medicine Ltd (class: not stated)
Collaborator
Innovate UK (class: other government)

Record details

Record id
cardio:ct-nct04559074
Content hash
c78457089d8ab72c71eab3766a51617e311fdde7b47210f7b5a6ccf1d0d58019